Sparstolonin B suppresses rat vascular smooth muscle cell proliferation, migration, inflammatory response and lipid accumulation

Vascular Pharmacology

Volumn 67, Issue , 2015, Pages 59-66

  Liu, Qing ^a,b   Li, Jianping ^a   Liang, Qiaoli ^c   Wang, Dawei ^b   Luo, Yi ^b   Yu, Fang ^d   Janicki, Joseph S ^a   Fan, Daping ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^c NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Atherogenesis; Inflammation; Lipid accumulation; Sparstolonin B; VSMC

Indexed keywords

ABC TRANSPORTER A1; ACETYL LOW DENSITY LIPOPROTEIN; CD36 ANTIGEN; CHOLESTEROL; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; PROTEIN INHIBITOR; PROTEIN KINASE B; SPARSTOLONIN B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; FUSED HETEROCYCLIC RINGS; LIPID;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; ATHEROSCLEROSIS; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CELL STIMULATION; CELL VIABILITY; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; LIPID STORAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; THYMIDINE INCORPORATION ASSAY; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CELL MOTION; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; SMOOTH MUSCLE CELL; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; HETEROCYCLIC COMPOUNDS, 4 OR MORE RINGS; INFLAMMATION MEDIATORS; LIPIDS; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84929268860     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2015.03.015     Document Type: Article

References (54)

1. Faxon D.P., Creager M.A., Smith S.C., Pasternak R.C., et al. Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation 2004, 109:2595-2604.
2. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
3. Lusis A.J. Atherosclerosis. Nature 2000, 407:233-241.
4. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
5. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
6. Steinberg D. Hypercholesterolemia and inflammation in atherogenesis: two sides of the same coin. Mol Nutr Food Res 2005, 49:995-998.
7. Louis S.F., Zahradka P. Vascular smooth muscle cell motility: from migration to invasion. Exp Clin Cardiol 2010, 15:e75-e85.
8. Doran A.C., Meller N., McNamara C.A. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2008, 28:812-819.
9. Rudijanto A. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med Indones 2007, 39:86-93.
10. Yang X., Coriolan D., Murthy V., Schultz K., Golenbock D.T., Beasley D., et al. Proinflammatory phenotype of vascular smooth muscle cells: role of efficient Toll-like receptor 4 signaling. Am J Physiol Heart Circ Physiol 2005, 289:H1069-H1076.
11. Yang X., Murthy V., Schultz K., Tatro J.B., Fitzgerald K.A., Beasley D., et al. Toll-like receptor 3 signaling evokes a proinflammatory and proliferative phenotype in human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2006, 291:H2334-H2343.
12. Yang X., Coriolan D., Schultz K., Golenbock D.T., Beasley D. Toll-like receptor 2 mediates persistent chemokine release by Chlamydia pneumoniae-infected vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2005, 25:2308-2314.
13. Hong T.J., Ban J.E., Choi K.H., Son Y.H., et al. TLR-4 agonistic lipopolysaccharide upregulates interleukin-8 at the transcriptional and post-translational level in vascular smooth muscle cells. Vasc Pharmacol 2009, 50:34-39.
14. Stoll L.L., Denning G.M., Weintraub N.L. Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. Arterioscler Thromb Vasc Biol 2004, 24:2227-2236.
15. Shibata N., Glass C.K. Regulation of macrophage function in inflammation and atherosclerosis. J Lipid Res 2009, (50 Suppl.):S277-S281.
16. Castrillo A., Tontonoz P. Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation. Annu Rev Cell Dev Biol 2004, 20:455-480.
17. Joseph S.B., Bradley M.N., Castrillo A., Bruhn K.W., et al. LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 2004, 119:299-309.
18. Zhao, Y., Pennings, M., Hildebrand, R. B., Ye, D., et al., Enhanced foam cell formation, atherosclerotic lesion development, and inflammation by combined deletion of ABCA1 and SR-BI in Bone marrow-derived cells in LDL receptor knockout mice on western-type diet. Circ Res, 107, e20-31.
19. Mullick A.E., Soldau K., Kiosses W.B., Bell T.A., et al. Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J Exp Med 2008, 205:373-383.
20. Lacolley P., Regnault V., Nicoletti A., Li Z., Michel J.B. The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc Res 2012, 95:194-204.
21. Liang Q., Wu Q., Jiang J., Duan J., et al. Characterization of sparstolonin B, a Chinese herb-derived compound, as a selective Toll-like receptor antagonist with potent anti-inflammatory properties. J Biol Chem 2011, 286:26470-26479.
22. Liang Q., Yu F., Cui X., Duan J., et al. Sparstolonin B suppresses lipopolysaccharide-induced inflammation in human umbilical vein endothelial cells. Arch Pharm Res 2013, 36:890-896.
23. Liu Q., Wang J., Liang Q., Wang D., et al. Sparstolonin B attenuates hypoxia-reoxygenation-induced cardiomyocyte inflammation. Exp Biol Med (Maywood) 2014, 239:376-384.
24. Jiang F., Guo N., Dusting G.J. Modulation of nicotinamide adenine dinucleotide phosphate oxidase expression and function by 3',4'-dihydroxyflavonol in phagocytic and vascular cells. J Pharmacol Exp Ther 2008, 324:261-269.
25. Wei H., L'Ecuyer T., Vander Heide R.S. Effect of increased expression of cytoskeletal protein vinculin on ischemia-reperfusion injury in ventricular myocytes. Am J Physiol Heart Circ Physiol 2003, 284:H911-H918.
26. Haslam G., Wyatt D., Kitos P.A. Estimating the number of viable animal cells in multi-well cultures based on their lactate dehydrogenase activities. Cytotechnology 2000, 32:63-75.
27. Chen Y., Chen Y., Zhao L., Chen Y., et al. Inflammatory stress exacerbates hepatic cholesterol accumulation via disrupting cellular cholesterol export. J Gastroenterol Hepatol 2012, 27:974-984.
28. Du F., Yu F., Wang Y., Hui Y., et al. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2014, 34:759-767.
29. Andrae J., Gallini R., Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev 2008, 22:1276-1312.
30. Singh R.B., Mengi S.A., Xu Y.J., Arneja A.S., Dhalla N.S. Pathogenesis of atherosclerosis: a multifactorial process. Exp Clin Cardiol 2002, 7:40-53.
31. Perez-Vizcaino F., Cogolludo A., Moreno L. Reactive oxygen species signaling in pulmonary vascular smooth muscle. Respir Physiol Neurobiol 2010, 174:212-220.
32. Greig F.H., Kennedy S., Spickett C.M. Physiological effects of oxidized phospholipids and their cellular signaling mechanisms in inflammation. Free Radic Biol Med 2012, 52:266-280.
33. Zhang C., Zhao Y.X., Zhang Y.H., Zhu L., et al. Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells. Proc Natl Acad Sci U S A 2010, 107:15886-15891.
34. Rodriguez A. Novel molecular aspects of ghrelin and leptin in the control of adipobiology and the cardiovascular system. Obes Facts 2014, 7:82-95.
35. Haider U.G., Roos T.U., Kontaridis M.I., Neel B.G., et al. Resveratrol inhibits angiotensin II- and epidermal growth factor-mediated Akt activation: role of Gab1 and Shp2. Mol Pharmacol 2005, 68:41-48.
36. Chaussade C., Rewcastle G.W., Kendall J.D., Denny W.A., et al. Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling. Biochem J 2007, 404:449-458.
37. Kunjathoor V.V., Febbraio M., Podrez E.A., Moore K.J., et al. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem 2002, 277:49982-49988.
38. Iwata H., Aikawa M. Liver-artery interactions via the plasminogen-CD36 axis in macrophage foam cell formation: new evidence for the role of remote organ crosstalk in atherosclerosis. Circulation 2013, 127:1173-1176.
39. Collot-Teixeira S., Martin J., McDermott-Roe C., Poston R., McGregor J.L. CD36 and macrophages in atherosclerosis. Cardiovasc Res 2007, 75:468-477.
40. Chang Y.C., Lee T.S., Chiang A.N. Quercetin enhances ABCA1 expression and cholesterol efflux through a p38-dependent pathway in macrophages. J Lipid Res 2012, 53:1840-1850.
41. Yin K., Liao D.F., Tang C.K. ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport. Mol Med 2010, 16:438-449.
42. Vallejo J.G. Role of toll-like receptors in cardiovascular diseases. Clin Sci 2011, 121:1-10.
43. Edfeldt K., Swedenborg J., Hansson G.K., Yan Z.Q. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 2002, 105:1158-1161.
44. Geng H.L., Lu H.Q., Zhang L.Z., Zhang H., et al. Increased expression of Toll like receptor 4 on peripheral-blood mononuclear cells in patients with coronary arteriosclerosis disease. Clin Exp Immunol 2006, 143:269-273.
45. Li H., Sun B. Toll-like receptor 4 in atherosclerosis. J Cell Mol Med 2007, 11:88-95.
46. Carpenter K., Taylor S.E., van der Veen C., Williamson B.K., Ballantine J.A., Mitchinson M.J., et al. Lipids and oxidised lipids in human atherosclerotic lesions at different stages of development. Biochim Biophys Acta 1995, 1256:141-150.
47. Guo X., Nie L., Esmailzadeh L., Zhang J., Bender J.R., Sadeghi M.M., et al. Endothelial and smooth muscle-derived neuropilin-like protein regulates platelet-derived growth factor signaling in human vascular smooth muscle cells by modulating receptor ubiquitination. J Biol Chem 2009, 284:29376-29382.
48. Gerthoffer W.T. Mechanisms of vascular smooth muscle cell migration. Circ Res 2007, 100:607-621.
49. Chen Z., Lee F.Y., Bhalla K.N., Wu J. Potent inhibition of platelet-derived growth factor-induced responses in vascular smooth muscle cells by BMS-354825 (dasatinib). Mol Pharmacol 2006, 69:1527-1533.
50. Butoi E.D., Gan A.M., Manduteanu I., Stan D., et al. Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules. Biochim Biophys Acta 1813, 2011:2026-2035.
51. Jiang P., Xu J., Zheng S., Huang J., et al. 17Beta-estradiol down-regulates lipopolysaccharide-induced MCP-1 production and cell migration in vascular smooth muscle cells. J Mol Endocrinol 2010, 45:87-97.
52. Sadeghi M.M., Glover D.K., Lanza G.M., Fayad Z.A., Johnson L.L. Imaging atherosclerosis and vulnerable plaque. J Nucl Med 2010, 51(Suppl. 1):51S-65S.
53. Tan X., Yang L., Xian L., Huang J., et al. ATP-binding cassette transporter A1 (ABCA1) promotes arsenic tolerance in human cells by reducing cellular arsenic accumulation. Clin Exp Pharmacol Physiol 2014, 41:287-294.
54. Matsumoto K., Hirano K., Nozaki S., Takamoto A., et al. Expression of macrophage (Mphi) scavenger receptor, CD36, in cultured human aortic smooth muscle cells in association with expression of peroxisome proliferator activated receptor-gamma, which regulates gain of Mphi-like phenotype in vitro, and its implication in atherogenesis. Arterioscler Thromb Vasc Biol 2000, 20:1027-1032.